An increase in the levels of GSR in the brain tissue samples from individuals with AD indicates that there is a compensatory mechanism to restore the levels of GSH due to compromised levels of GCLC and GSS enzymes (Figs. 2A, 3A). This evidence concerns the gene GCLC and Alzheimer disease.